Mistletoe therapy is an injectable botanical treatment derived from extracts of the Viscum album plant. It has been used for several decades in integrative medical settings.
Mistletoe extracts are administered through small subcutaneous injections, usually into the skin of the abdomen or thigh.
In clinical practice, mistletoe injections are prescribed following medical assessment and are administered according to individualized treatment protocols.
Because mistletoe extract is a prescription therapy, it is important to distinguish between on-label and off-label uses.
On-Label Use
Internationally, mistletoe therapy is most commonly used as an adjunct therapy in integrative oncology.
In these settings it may be incorporated into supportive care programs alongside conventional cancer treatments.
While cancer care is the most widely recognized application of mistletoe therapy, oncology care is not a primary clinical focus of this practice. Patients undergoing cancer treatment should always consult with their oncology care team when considering complementary therapies.
Off-Label Uses
Outside of oncology, mistletoe therapy is sometimes used in integrative medicine settings for conditions involving chronic inflammation or immune dysregulation.
In this practice, mistletoe injections may be considered as part of care for:
Use for these indications is considered off-label and requires careful clinical assessment and monitoring.
One of the primary applications of mistletoe injections in this practice is for the management of osteoarthritis-related pain and inflammation.
Some integrative medicine protocols explore mistletoe extract for its potential influence on inflammatory pathways and immune signaling involved in chronic joint disease.
Treatment programs for osteoarthritis may involve:
Treatment schedules vary depending on the severity of symptoms and patient response.
HPV (Human Papillomavirus)
Persistent viral infections such as HPV involve complex interactions between the immune system and epithelial tissues.
Some integrative protocols explore immune-supportive therapies as part of broader management strategies. Mistletoe therapy may occasionally be considered in these contexts following clinical evaluation.
Endometriosis
Endometriosis involves inflammatory and immune-related mechanisms that contribute to the persistence of endometrial tissue outside the uterus.
Some integrative medicine approaches explore therapies that influence immune signaling and inflammatory pathways when managing symptoms related to endometriosis.
Use of mistletoe therapy in this context would be considered off-label and evaluated on an individual basis.
Mistletoe injections are typically administered subcutaneously, meaning the injection is placed just under the skin.
A typical treatment program may involve:
Some treatment programs may also transition to self-administration at home once patients are comfortable with the process.
Mistletoe therapy often produces mild immune responses.
Common reactions may include:
These reactions are discussed during informed consent and monitored throughout treatment.
